Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers

Clinical trial NCT05019950 · COMPLETED

Trial details

NCT number: NCT05019950
Sponsor: NImmune Biopharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Normal Healthy Volunteers

Start date: 2021-10-28
Primary completion: 2022-04-28
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.